(Q40609208)

22 September 2017

title

Interleukin 4 therapy for patients with chronic lymphocytic leukaemia: a phase I/II study (English)

1 reference

22 September 2017

0 references

1 reference

Lundin J

1

1 reference

22 September 2017

Kimby E

2

1 reference

22 September 2017

Bergmann L

3

1 reference

22 September 2017

Karakas T

4

1 reference

22 September 2017

Mellstedt H

5

1 reference

22 September 2017

Osterborg A

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

British Journal of Haematology

22 September 2017

published in

1 reference

22 September 2017

volume

112

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

155-160

1 reference

Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02525.X

Programmed cell death: the influence of CD40, CD95 (Fas or Apo-I) and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02525.X

Human interleukin-4: An immunomodulator with potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02525.X

Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02525.X

Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02525.X

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02525.X

fas-mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokines and autologous fasL-expressing T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02525.X

10.1046/J.1365-2141.2001.02525.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference